PMID- 18550280 OWN - NLM STAT- MEDLINE DCOM- 20080915 LR - 20240312 IS - 0304-3940 (Print) IS - 0304-3940 (Linking) VI - 440 IP - 2 DP - 2008 Aug 1 TI - Characterization of trkB immunoreactive cells in the intermediolateral cell column of the rat spinal cord. PG - 103-8 LID - 10.1016/j.neulet.2008.05.057 [doi] AB - The objective of the present study was to characterize the trkB receptor immunoreactive (-ir) cells in the intermediolateral cell column (IML) of the upper thoracic spinal cord. Small trkB-ir cells (area=56.1+/-4.4 microm(2)) observed in the IML showed characteristics of oligodendrocytes and were frequently observed in close apposition to choline acetyltransferase (ChAT)-ir cell bodies. Large trkB-ir cells (area=209.3+/-25.2 microm(2)) showed immunoreactivity for the neuronal marker NeuN, indicating their neuronal phenotype, as well as for ChAT, a marker for preganglionic neurons. TrkB and ChAT were co-localized in IML neurons primarily in cases that had received in vivo administration of nerve growth factor (NGF). These findings reveal two different cell types, oligodendrocytes and neurons, in the IML of the spinal cord that show trkB immunoreactivity, suggesting their regulation by brain derived neurotrophic factor (BDNF) and/or neurotrophin-4 (NT-4). In addition, there is evidence that NGF may play a role in the regulation of trkB-ir preganglionic neurons in the IML. FAU - McCartney, Annemarie M AU - McCartney AM AD - Center for Neuroscience and Behavior, Department of Zoology, Miami University, 280 Pearson Hall, Oxford, OH 45056, United States. FAU - Abejuela, Vanessa L AU - Abejuela VL FAU - Isaacson, Lori G AU - Isaacson LG LA - eng GR - R15 NS051206/NS/NINDS NIH HHS/United States GR - R15 NS051206-01/NS/NINDS NIH HHS/United States GR - NS051206/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20080521 PL - Ireland TA - Neurosci Lett JT - Neuroscience letters JID - 7600130 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Nerve Growth Factors) RN - 9061-61-4 (Nerve Growth Factor) RN - EC 2.3.1.6 (Choline O-Acetyltransferase) RN - EC 2.7.10.1 (Receptor, trkB) RN - P658DCA9XD (neurotrophin 4) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/analysis MH - Choline O-Acetyltransferase/metabolism MH - Immunohistochemistry MH - Injections, Intraventricular MH - Microscopy, Confocal MH - Nerve Growth Factor/administration & dosage/pharmacology MH - Nerve Growth Factors/analysis MH - Neurons/cytology/drug effects/*metabolism MH - Oligodendroglia/cytology/drug effects/*metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Receptor, trkB/*metabolism MH - Spinal Cord/cytology/drug effects/*metabolism PMC - PMC2525737 MID - NIHMS57953 EDAT- 2008/06/14 09:00 MHDA- 2008/09/16 09:00 PMCR- 2009/08/01 CRDT- 2008/06/14 09:00 PHST- 2008/03/21 00:00 [received] PHST- 2008/05/09 00:00 [revised] PHST- 2008/05/10 00:00 [accepted] PHST- 2008/06/14 09:00 [pubmed] PHST- 2008/09/16 09:00 [medline] PHST- 2008/06/14 09:00 [entrez] PHST- 2009/08/01 00:00 [pmc-release] AID - S0304-3940(08)00658-7 [pii] AID - 10.1016/j.neulet.2008.05.057 [doi] PST - ppublish SO - Neurosci Lett. 2008 Aug 1;440(2):103-8. doi: 10.1016/j.neulet.2008.05.057. Epub 2008 May 21.